Board of Directors and Doing Business in China Under the FCPA

Lesenswert für Firmenvertreter mit Geschäftsaktivitäten in China (und erst recht dann, wenn zudem eine Tochtergesellschaft in den USA existiert – wegen des „langen Arms“ der U.S. Gesetze): The case of GlaxoSmithKline PLC (GSK) is still resonating across the corporate globe. While many questions are still unanswered, one that seems to be at the forefront of the inquiry was where was the GSK Board of Directors? The role of a Board of Directors is becoming more important and more of a critical part of any effective compliance program. Indeed Board involvement is listed as one of the ten hallmarks of an effective compliance program, set out in last year’s FCPA Guidance. In addition to helping to set the proper tone in an organization, the Board has a specific oversight role in any Foreign Corrupt Practices Act (FCPA) or UK Bribery Act compliance program. Hier der vollständige Artikel.